Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

82.52 +1.15 (+1.41%)
Official Closing Price Updated: 7:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
62 63 Next >
Humana Stock Dives On Medicare Ratings; UnitedHealth Tries To Bounce
Humana Medicare Advantage plans are getting a big star-ratings cut. 
Via Investor's Business Daily
What Analysts Are Saying About CVS Health Stock
 
Via Benzinga
CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report
CVS Health explores splitting its retail and insurance units to address investor concerns and financial challenges. The potential breakup could unwind the $70 billion Aetna acquisition made in 2017. 
Via Benzinga
Instacart Is Revolutionizing Groceries: Why It's Time to Invest
It can be confusing, but Maplebear Inc. (NASDAQ: CART) is better known as Instacart, the world's largest online grocery marketplace. 
Via MarketBeat
Topics Artificial Intelligence
Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today
U.S. markets closed Monday slightly higher, with the Dow Jones Industrial Average edging up 0.04% to 42,330.15. 
Via Benzinga
Topics Stocks
Stock Of The Day: Is It Time To Sell CVS?
The chart of CVS (CVS) shows two important market principles. There tends to be resistance at former peaks and support at former bottoms. 
Via Benzinga
CVS Health's Options: A Look at What the Big Money is Thinking
 
Via Benzinga
CVS Health in Focus as Activist Investor Prepares for High-Level Talks
CVS Health is under pressure from hedge fund Glenview Capital as the company grapples with stock price drops, financial struggles with Medicare, and legal scrutiny of its pharmacy-benefit unit. 
Via Benzinga
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Here’s Why Surgery Partners Could Be the Next Hot Takeover
Surgery Partners is the third-largest operator of ambulatory surgery centers (ASCs) in the United States, with over 200 locations. 
Via MarketBeat
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
The FTC is going after these PBMs. Is this an opportunity for investors? 
Via The Motley Fool
Spotlight on CVS Health: Analyzing the Surge in Options Activity
 
Via Benzinga
Is CVS Health Stock a Buy?
It's been a year to forget for the healthcare company. 
Via The Motley Fool
Behind the Scenes of CVS Health's Latest Options Trends
 
Via Benzinga
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices. 
Via Benzinga
Topics Lawsuit
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
FTC files a complaint against CVS, Cigna, and UnitedHealth's PBMs, accusing them of inflating insulin prices through a rebate-driven system. The case aims to address unfair practices and improve access... 
Via Benzinga
Topics Lawsuit
Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules
Eli Lilly appeals a $183 million judgment in a Medicaid fraud case, arguing that it followed a reasonable interpretation of the law. The case has drawn attention from major business and pharmaceutical... 
Via Benzinga
Topics Fraud
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
 
Via Benzinga
What 9 Analyst Ratings Have To Say About CVS Health
 
Via Benzinga
CVS Subsidiary Oak Street Health Agrees to $60M Settlement in Medicare Kickback Violations
Oak Street Health has agreed to pay $60 million to settle claims that it violated the False Claims Act by providing kickbacks to agents for recruiting seniors to its Medicare Advantage clinics,... 
Via Benzinga
Topics Lawsuit
4 Dividend Stocks to Double Up On Right Now
Dividend investing is a powerful way to build wealth and financial security. 
Via The Motley Fool
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Walgreens Agrees To $106.8M Settlement Over Alleged False Billing Claims
Walgreens agrees to pay $106.8 million to settle claims of false billing to federal health care programs. The settlement addresses fraudulent activities between 2009 and 2020 and includes significant... 
Via Benzinga
Topics Lawsuit Whistleblower
3 Overlooked Stocks With Strong Value and Dividend Potential
Three forgotten-about, sluggishly performing defensive stocks that could offer value and income potential over the long term. 
Via MarketBeat
PayPal Is A Buy, Jim Cramer Says: As For Rivian? 'Let It Percolate'
PayPal will become an additional credit and debit card processor for Shopify Payments through its PayPal Complete Payments solution. 
Via Benzinga
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs. 
Via Benzinga
CVS Shares Are Trading Lower Wednesday: What You Need To Know
CVS Health Corporation (NYSE: CVS) shares are seeing a The sell-off comes in the wake of the recent Trump-Harris debate, which has created a wave of uncertainty in the healthcare sector. Here's what... 
Via Benzinga
Interest Rates, Private Equity, Stocks, Football...We've Got It All
Including an interview with former NFL linebacker Brandon Copeland. 
Via The Motley Fool
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated to education, recovery centers, and outreach initiatives. 
Via Benzinga
CVS Investors Have Opportunity to Join CVS Health Corporation Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
62 63 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.